We’ll see if any real solid news comes out confirming or denying the talk out there. Until then, it’s just another stock moving on rumors.
“It is our opinion, along with that of many other market professionals, that this current market is overbought. An overbought market often searches for a place, or more to the point, a reason to pull This is why fear in the markets should create …
Fibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, …
ALISO VIEJO, Calif., April 26 /PRNewswire/ -- While the aesthetic industry was significantly impacted by the economic recession of 2008 and 2009, sales have begun to rebound as consumers and businesses resume spending, according …
Copyright Š 1990 by William T. Still reser~.-ed. No part of this book may be reproduced without permission from -the publisher, except by a reviewer who may quote brief passages in a review; nor may any part of this book be reproduced, …
issuu5mon
Affymax Inc. (NASDAQ: AFFY) has been in more than trouble. Its very future is at stake as far as investors (and speculators) are concerned. The company is restructuring, but this ... Read Full Story »
EDITOR’S COMMENTS..... 2 CONTRIBUTORS..... 4 ...